Venus Remedies has entered into agreement to sell its patented product Elores to Cipla for the Indian Territory. This association with Cipla will enable greater patient access of Elores in India. Elores is a novel combination of Ceftriaxone. Sulbactam and Disodium EDTA indicated for the treatment of life-threatening infections caused by gram-negative bacteria.
The present deal with Cipla for Indian Territory will enable VRL to focus its efforts on strengthening its global position for Elores. Currently, Elores is available in 7 countries and is scheduled to be launched in another 4 territories over the next 12 months; it is under registration in many other parts of world.
Venus Remedies is a pharmaceutical manufacturing company. The company is engaged in manufacturing products catering to various segments such as Oncology, Cephalosporins, Carbapenems and Other Specialties.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: